HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Srinivas Sriramula Selected Research

Acetates (Acetic Acid Esters)

1/2023Kinin B1 Receptor Mediates Bidirectional Interaction between Neuroinflammation and Oxidative Stress.
10/2021Hypothalamic kinin B1 receptor mediates orexin system hyperactivity in neurogenic hypertension.
12/2017Kinin B1 Receptor Promotes Neurogenic Hypertension Through Activation of Centrally Mediated Mechanisms.
6/2017Clinical Relevance and Role of Neuronal AT1 Receptors in ADAM17-Mediated ACE2 Shedding in Neurogenic Hypertension.
3/2015Brain-targeted angiotensin-converting enzyme 2 overexpression attenuates neurogenic hypertension by inhibiting cyclooxygenase-mediated inflammation.
3/2015Brain ACE2 overexpression reduces DOCA-salt hypertension independently of endoplasmic reticulum stress.
10/2013Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Srinivas Sriramula Research Topics

Disease

25Hypertension (High Blood Pressure)
01/2023 - 05/2008
8Neuroinflammatory Diseases
01/2023 - 03/2015
7Fibrosis (Cirrhosis)
01/2023 - 06/2009
6Inflammation (Inflammations)
01/2023 - 10/2013
4Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 09/2010
4Cardiomegaly (Heart Hypertrophy)
01/2015 - 05/2008
3Pulmonary Hypertension
10/2010 - 06/2009
2COVID-19
01/2023 - 01/2022
2Myocardial Infarction
01/2023 - 03/2011
2Heart Failure
11/2022 - 03/2011
2Pulmonary Fibrosis (Fibrosing Alveolitis)
10/2010 - 06/2009
2Right Ventricular Hypertrophy
10/2010 - 06/2009
1Mental Disorders (Mental Disorder)
11/2022
1Chronic Kidney Failure (Chronic Renal Failure)
01/2021
1Chronic Renal Insufficiency
01/2021
1Kidney Diseases (Kidney Disease)
01/2021
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2020
1Nervous System Diseases (Neurological Disorders)
08/2018
1Hypertrophy
01/2015
1Ventricular Remodeling
01/2015
1Body Weight (Weight, Body)
01/2015
1Necrosis
12/2011
1Acute Lung Injury
08/2009
1Lung Diseases (Lung Disease)
06/2009
1Mitochondrial Diseases (Mitochondrial Disease)
11/2007

Drug/Important Bio-Agent (IBA)

13Angiotensin IIIBA
01/2023 - 05/2008
10SaltsIBA
01/2023 - 05/2008
10CytokinesIBA
01/2023 - 05/2008
9KininsIBA
01/2023 - 12/2017
7Acetates (Acetic Acid Esters)FDA Link
01/2023 - 10/2013
7Desoxycorticosterone (Deoxycorticosterone)IBA
01/2023 - 10/2013
7Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2013
6Angiotensin-Converting Enzyme 2IBA
01/2023 - 06/2009
5Desoxycorticosterone Acetate (DOCA)FDA Link
01/2023 - 03/2015
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2015 - 11/2007
4Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
06/2017 - 10/2010
2Interleukin-6 (Interleukin 6)IBA
01/2023 - 12/2011
2CollagenIBA
11/2022 - 01/2021
2Dopamine Receptors (Dopamine Receptor)IBA
11/2022 - 01/2021
21- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2022 - 11/2007
2Metalloproteases (Metalloproteinases)IBA
12/2020 - 06/2017
2DisintegrinsIBA
12/2020 - 06/2017
2Norepinephrine (Noradrenaline)FDA LinkGeneric
12/2018 - 08/2010
2Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2015 - 03/2011
2EnzymesIBA
03/2015 - 08/2009
2Etanercept (Enbrel)FDA Link
01/2015 - 01/2013
2AngiotensinsIBA
01/2013 - 10/2010
2Superoxides (Superoxide)IBA
03/2011 - 06/2009
2NF-kappa B (NF-kB)IBA
12/2009 - 06/2009
1Toll-Like Receptor 4IBA
01/2023
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2023
1Dopamine AntagonistsIBA
11/2022
1Antipsychotic Agents (Antipsychotics)IBA
11/2022
1Arginine Vasopressin (Argipressin)IBA
10/2021
1OrexinsIBA
10/2021
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2021
1Glutamic Acid (Glutamate)FDA Link
08/2018
1LigandsIBA
12/2017
1BradykininIBA
12/2017
1Messenger RNA (mRNA)IBA
12/2017
1Lysine Carboxypeptidase (Carboxypeptidase N)IBA
12/2017
1Mitogen-Activated Protein KinasesIBA
03/2015
1AntioxidantsIBA
03/2015
1Superoxide DismutaseIBA
03/2015
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
03/2015
1ursodoxicoltaurineIBA
03/2015
13-nitrotyrosineIBA
03/2015
1CatalaseIBA
03/2015
1leupeptinIBA
12/2014
1angiotensin I (1-7)IBA
10/2013
1Antihypertensive Agents (Antihypertensives)IBA
01/2013
1Transcription Factors (Transcription Factor)IBA
01/2012
1InterleukinsIBA
12/2011
1Bleomycin (Blenoxane)FDA LinkGeneric
10/2010
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2010
1Hydralazine (Apresoline)FDA LinkGeneric
09/2010
1Histone Deacetylases (Histone Deacetylase)IBA
09/2010
1Minocycline (Cyclops)FDA LinkGeneric
08/2010
1Anti-Bacterial Agents (Antibiotics)IBA
08/2010
1MonocrotalineIBA
06/2009
1Vasodilator Agents (Vasodilators)IBA
06/2009
1tempolIBA
11/2007

Therapy/Procedure

6Therapeutics
01/2023 - 05/2008
1Cannula
03/2011
1Ligation
03/2011
1Intraventricular Infusions
08/2010